European Commission launches feedback platform on BPA in food packaging

Assessing health risks

The European lawmakers will discuss appropriate regulatory measures to protect consumers based on EFSA’s scientific advice.

“EFSA’s assessments are based on the latest scientific knowledge and evidence. On BPA, EFSA scrutinized a vast quantity of scientific publications, including over 800 new studies. This allowed us to address important uncertainties about BPA’s toxicity,” stresses the EFSA spokesperson.

“Our experts also took into account other potentially harmful health effects on the reproductive, developmental and metabolic systems identified in the risk assessment,” says the EFSA spokesperson.

Packaging exposure

BPA can migrate in tiny amounts into the contents of the containers.

“This is why it is called ‘leachable.’ BPA may also be present in primary packaging material and manufacturing equipment used in the manufacturing process of medicines, in medicine containers, medicine or device combinations, and, for example, blood bags and bags with parenteral nutrition,” explains the EC spokesperson.